Transdermal microneedle patch with photothermal effect as well as preparation method and application of transdermal microneedle patch

By encapsulating Fe3O4 nanoparticles and gel matrix in transdermal microneedle patches, local thermal therapy is generated using near-infrared light, the problem of low drug delivery efficiency of existing microneedle patches is solved, and efficient drug delivery and local warmth are achieved Thermal therapy enhances the therapeutic effect and expands the scope of application.

CN118902977APending Publication Date: 2024-11-08THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410940098.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing transdermal microneedle patches have limited their application range in disease treatment.

Method used

A transdermal microneedle patch with photothermal effect was designed. By encapsulating Fe3O4 nanoparticles and gel matrix in the microneedle tip, local mild thermal therapy was generated using near-infrared light irradiation to improve the therapeutic effect and safety.

Benefits of technology

It realizes efficient drug delivery and locally controlled mild thermal therapy, enhances the therapeutic effect, reduces side effects, and is suitable for individualized and long-term treatment, expanding the application field.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118902977A_ABST
    Figure CN118902977A_ABST
Patent Text Reader

Abstract

The invention provides a transdermal microneedle patch with a photothermal effect as well as a preparation method and application of the transdermal microneedle patch, and belongs to the technical field of medical materials. According to the transdermal microneedle patch provided by the invention, the Fe3O4 nanoparticles serving as a photothermal conversion agent are encapsulated in the tip of the microneedle patch, so that the photothermal conversion efficiency is high, and the temperature is controllable. The transdermal microneedle patch provided by the invention is strong in skin penetrating power and convenient to operate, can cooperate with photothermal therapy, has the unique advantages of higher selectivity, minimum invasiveness and side effects and capability of realizing local controllable mild thermal therapy, and shows very wide application prospects in clinical disease treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical materials, and in particular to a transdermal microneedle patch with photothermal effect, a preparation method and application thereof. Background Art

[0002] Microneedle patch (MNP) is an emerging transdermal drug delivery technology, which consists of multiple micron-sized needle tips arranged in an array on a base. MNP can pierce the stratum corneum of the skin, forming micron-sized channels, and deliver drugs to the skin with minimally invasive and precise control to participate in the microcirculation in the body, thereby achieving therapeutic effects. Compared with traditional invasive injection and / or oral drug delivery strategies, MNP drug delivery systems do not stimulate pain-related nerve endings, have the advantages of minimally invasive, painless, precise drug delivery, flexibility and ease of application, and are suitable for individualized and long-term treatment of diseases. In recent years, MNP drug delivery systems have been widely studied in different disease fields such as wounds, tumors, diabetes, obesity, hair loss and skin diseases, but there are still disadvantages such as small dosage, insufficient drug diffusion and poor therapeutic effect. In order to further improve the therapeutic effect and expand the application field of MNP, MNP is currently being combined with a variety of treatment strategies (such as phototherapy, cell therapy, gas therapy and gene therapy) for synergistic treatment, and has broad application prospects in the field of disease treatment.

[0003] Photothermal therapy (PTT) is an emerging disease treatment method. Its mechanism of action is to use materials with high photothermal conversion efficiency to generate enough heat under near-infrared (NIR) light to achieve local hyperthermia. MNP-assisted PTT can achieve the combination of photothermal therapy and drug therapy to improve the therapeutic effect and safety, and has been used as a promising alternative treatment for many diseases. Therefore, designing a transdermal microneedle drug delivery system with photothermal effect has great clinical application value in the field of disease treatment. Summary of the invention

[0004] In view of this, the purpose of the present invention is to provide a transdermal microneedle patch with photothermal effect and its preparation method and application. The transdermal microneedle patch with photothermal effect provided by the present invention has good photothermal conversion efficiency and can achieve controllable mild thermal therapy for the local treatment area under the irradiation of near-infrared laser.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides a transdermal microneedle patch with photothermal effect, comprising a microneedle base and a plurality of microneedle tips arranged in an array and disposed on the surface of the microneedle base;

[0007] The components of the microneedle tip include a gel matrix and Fe 3 O 4 Nanoparticles; the raw materials of the gel matrix include hyaluronic acid and / or sodium alginate.

[0008] Preferably, the Fe 3 O 4 The particle size of the nanoparticles is 5 to 20 nm.

[0009] Preferably, in the microneedle tip, Fe 3 O 4 The mass ratio of the nanoparticles to the gel matrix is ​​0.002-0.02:0.2-2.

[0010] Preferably, the shape of the microneedle tip is a quadrangular pyramid, and the bottom side length of a single microneedle tip is 100 to 1000 μm, and the height is 300 to 1500 μm.

[0011] Preferably, the raw material of the microneedle base includes hyaluronic acid.

[0012] The present invention provides a method for preparing the above-mentioned transdermal microneedle patch with photothermal effect, comprising the following steps:

[0013] Fe 3 O 4 The raw materials of nanoparticles, gel matrix and water are mixed to obtain the needle tip solution;

[0014] Mixing the raw materials of the microneedle base with water to obtain a base solution;

[0015] The needle tip solution is poured onto the needle tip portion of the microneedle patch mold, and after a first centrifugation and a first drying, the base solution is poured onto the base portion of the microneedle patch mold, and a second centrifugation, a second drying and demoulding are performed to obtain a transdermal microneedle patch with a photothermal effect.

[0016] Preferably, Fe 3 O 4 The concentration of the nanoparticles is 0.1-1.0 mg / mL.

[0017] Preferably, the concentration of the base solution is 3-6 w / v%.

[0018] Preferably, the first centrifugation and the second centrifugation are performed at a rate of 250 to 4500 rpm and for a time of 5 to 15 min;

[0019] The temperature of the first drying and the second drying is 25-45°C.

[0020] The present invention provides the use of the above-mentioned transdermal microneedle patch with photothermal effect in the preparation of photothermal therapy medical materials.

[0021] The present invention provides a transdermal microneedle patch (abbreviated as Fe 3 O 4 @MNP), comprising a microneedle base and a plurality of microneedle tips arranged in an array on the surface of the microneedle base; the components of the microneedle tips include a gel matrix and Fe 3 O 4 Nanoparticles; the raw materials of the gel matrix include hyaluronic acid and / or sodium alginate. 3 O 4 Nanoparticles are magnetic nanoparticles with the advantages of low cost, high biocompatibility and enzyme-like activity. They have been approved by the FDA for use in humans and have a wide range of applications in biomedical fields such as biosensors, drug delivery, magnetic resonance imaging, tissue engineering, magnetic hyperthermia and anti-oxidative stress damage. 3 O 4 Nanoparticles also have excellent photothermal conversion capabilities and can be used as excellent photosensitizer candidates in photothermal therapy to participate in the treatment of diseases. 3 O 4 Nanoparticles are encapsulated in the tip of the microneedle patch, with high photothermal conversion efficiency and controllable temperature. The transdermal microneedle patch provided by the present invention has strong skin penetration ability, convenient operation, can cooperate with photothermal therapy, has higher selectivity, minimal invasiveness and side effects, and can achieve local controllable mild heat therapy, showing a very broad application prospect in the treatment of clinical diseases.

[0022] The present invention provides a method for preparing the above-mentioned transdermal microneedle patch with photothermal effect, which is simple to operate, low in cost, stable in quality, and easy to realize industrial mass production. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 The flowchart of the preparation of the transdermal microneedle patch with photothermal effect;

[0024] Figure 2 Fe obtained in Example 1 3 O 4 Digital photo taken by @MNP;

[0025] Figure 3 Fe obtained in Example 1 3 O 4 @Optical microscopy image of MNP;

[0026] Figure 4 Fe obtained in Example 1 3 O4 @Scanning electron microscopy image of MNP;

[0027] Figure 5 Fe obtained in Example 1 3 O 4 @Energy dispersion spectrum of MNP tip;

[0028] Figure 6 Fe obtained in Example 1 3 O 4 @MNP mechanical displacement curve;

[0029] Figure 7 Fe obtained in Example 1 3 O 4 @MNP’s digital photo of pig skin puncture;

[0030] Figure 8 Fe obtained in Example 1 3 O 4 @Temperature rise curve of MNP under NIR irradiation of different powers;

[0031] Fig. 9 Fe obtained in Example 1 3 O 4 @Infrared thermal imaging of MNP before and after NIR irradiation for 5 minutes;

[0032] Fig.10 Fe obtained in Example 1 3 O 4 @Temperature variation of MNP during laser on / off cycle experiment;

[0033] Fig.11 Example 1 in mice Fe 3 O 4 @In vivo photothermal performance of MNPs;

[0034] Fig.12 Fe obtained in Example 2 3 O 4 Digital photo taken by @MNP;

[0035] Fig.13 Fe obtained in Example 2 3 O 4 @Optical microscopy image of MNP;

[0036] Fig.14 Fe obtained in Example 2 3 O 4 @MNP’s digital photo of pig skin puncture;

[0037] Fig.15 Fe obtained in Example 23 O 4 @Temperature rise curve of MNP under NIR irradiation;

[0038] Fig.16 Fe obtained in Example 2 3 O 4 @Infrared thermal imaging of MNP before and after NIR irradiation for 5 minutes;

[0039] Fig.17 Fe obtained in Example 3 3 O 4 Digital photo taken by @MNP;

[0040] Fig.18 Fe obtained in Example 3 3 O 4 @Optical microscopy image of MNP;

[0041] Fig.19 Fe obtained in Example 3 3 O 4 @MNP’s digital photo of pig skin puncture;

[0042] Fig. 20 Fe obtained in Example 3 3 O 4 @Temperature rise curve of MNP under NIR irradiation;

[0043] Fig.21 Fe obtained in Example 3 3 O 4 @Infrared thermal imaging of MNP before and after NIR irradiation for 5 minutes;

[0044] Fig. 22 Fe obtained in Example 4 3 O 4 Digital photo taken by @MNP;

[0045] Fig.23 Fe obtained in Example 4 3 O 4 @Optical microscopy image of MNP;

[0046] Fig.24 Fe obtained in Example 4 3 O 4 @MNP’s digital photo of pig skin puncture;

[0047] Fig.25 Fe obtained in Example 4 3 O 4 @Temperature rise curve of MNP under NIR irradiation;

[0048] Fig.26 Fe obtained in Example 4 3 O 4 @Infrared thermal imaging of MNP before and after NIR irradiation for 5 minutes;

[0049] Fig. 27 Fe obtained in Example 5 3 O 4 Digital photo taken by @MNP;

[0050] Fig.28 Fe obtained in Example 5 3 O 4 @Optical microscopy image of MNP;

[0051] Fig.29 Fe obtained in Example 5 3 O 4 @MNP’s digital photo of pig skin puncture;

[0052] Fig.30 Fe obtained in Example 5 3 O 4 @Temperature rise curve of MNP under NIR irradiation;

[0053] Fig.31 Fe obtained in Example 5 3 O 4 @Infrared thermal imaging of MNP before and after NIR irradiation for 5 minutes;

[0054] Fig.32 Fe obtained in Example 6 3 O 4 Digital photo taken by @MNP;

[0055] Fig.33 Fe obtained in Example 6 3 O 4 @Optical microscopy image of MNP;

[0056] Fig.34 Fe obtained in Example 6 3 O 4 @MNP’s digital photo of pig skin puncture;

[0057] Fig.35 Fe obtained in Example 6 3 O 4 @Temperature rise curve of MNP under NIR irradiation;

[0058] Fig.36 Fe obtained in Example 6 3 O 4 @Infrared thermal imaging of MNP before NIR irradiation and after NIR irradiation for 5 minutes. DETAILED DESCRIPTION

[0059] The present invention provides a transdermal microneedle patch with photothermal effect, comprising a microneedle base and a plurality of microneedle tips arranged in an array and disposed on the surface of the microneedle base;

[0060] The components of the microneedle tip include a gel matrix and Fe 3 O 4 Nanoparticles; the raw materials of the gel matrix include hyaluronic acid and / or sodium alginate.

[0061] In the present invention, in the microneedle tip, the Fe 3 O 4 The particle size of the nanoparticles is preferably 5 to 20 nm, more preferably 10 nm; the Fe 3 O 4 The mass ratio of the nanoparticles to the gel matrix is ​​preferably 0.002-0.02:0.2-2, more preferably 0.005-0.01:0.5-1.

[0062] In the present invention, the shape of the microneedle tip is preferably a quadrangular pyramid, the bottom side length of a single microneedle tip is preferably 100-1000 μm, more preferably 400 μm, the height is preferably 300-1500 μm, more preferably 900 μm, and the distance between adjacent microneedle tips is preferably 500-1000 μm, more preferably 600-800 μm. As a specific embodiment of the present invention, the microneedle tips are neatly arranged on the microneedle base in a 20×20 array.

[0063] In the present invention, the raw material of the microneedle base preferably includes hyaluronic acid. In the present invention, the thickness of the microneedle base is preferably 1 to 5 mm, more preferably 1 to 4 mm.

[0064] The present invention provides a method for preparing the above-mentioned transdermal microneedle patch with photothermal effect, comprising the following steps:

[0065] Fe 3 O 4 The raw materials of nanoparticles, gel matrix and water are mixed to obtain the needle tip solution;

[0066] Mixing the raw materials of the microneedle base with water to obtain a base solution;

[0067] The needle tip solution is poured onto the needle tip portion of the microneedle patch mold, and after a first centrifugation and a first drying, the base solution is poured onto the base portion of the microneedle patch mold, and a second centrifugation, a second drying and demoulding are performed to obtain a transdermal microneedle patch with a photothermal effect.

[0068] In the present invention, unless otherwise specified, the raw materials used are commercially available products well known in the art.

[0069] The present invention uses Fe 3 O 4 Nanoparticles, raw materials of gel matrix and water are mixed to obtain needle tip solution. In the present invention, the raw materials of the gel matrix are preferably hyaluronic acid and / or sodium alginate. In the present invention, Fe 3 O 4 The concentration of the nanoparticles is preferably 0.1 to 1.0 mg / mL, more preferably 0.4 to 0.6 mg / mL, and the concentration of the gel matrix is ​​preferably 1 to 10 w / v%, i.e. 1 to 10% (w / v), more preferably 2 to 8% (w / v). In the present invention, the 1 to 10 w / v% means that the mass of the gel matrix is ​​1 to 10 g, more preferably 2 to 8 g, based on 100 mL of water. As a specific embodiment of the present invention, the Fe 3 O 4 The dosage ratio of nanoparticles to water is preferably 2-20 mg: 20 mL. 3 O 4 The preferred usage ratio of nanoparticles to gel matrix is ​​2-20 mg: 0.2-2.0 g.

[0070] In the present invention, the mixing method is preferably: firstly Fe 3 O 4 The nanoparticles and water are vortexed and ultrasonicated to form a uniformly dispersed solution, and then the raw materials of the gel matrix are added for mechanical stirring.

[0071] The present invention mixes the raw material of the microneedle base with water to obtain a base solution. In the present invention, the raw material of the microneedle base is preferably hyaluronic acid. In the present invention, the mixing method is preferably mechanical stirring. In the present invention, the concentration of the base solution is preferably 3-6% (w / v), more preferably 5% (w / v). In the present invention, the 3-6% (w / v) means that the mass of the raw material of the microneedle base is 3-6g, more preferably 5g, based on 100mL of water.

[0072] The present invention pours the needle tip solution into the needle tip part of the microneedle patch mold, pours the base solution into the base part of the microneedle patch mold after the first centrifugation and the first drying, performs the second centrifugation, the second drying and demoulding, and obtains a transdermal microneedle patch with a photothermal effect. In the present invention, the shape of the microneedle patch mold corresponds to the shape of the transdermal microneedle patch. In the present invention, the material of the microneedle patch mold is preferably polydimethylsiloxane (PDMS). In the present invention, the rate of the first centrifugation is preferably 250 to 4500 rpm, more preferably 4500 rpm, and the time is preferably 5 to 15 min, more preferably 10 min. The present invention uses the centrifugation to fully fill the microneedle tip gap with the needle tip solution.

[0073] In the present invention, the first drying is preferably performed in a blast drying oven, and the temperature of the first drying is preferably 25-45°C, more preferably 37°C.

[0074] In the present invention, the second centrifugation speed is preferably 250-4500 rpm, more preferably 4500 rpm, the time is preferably 5-15 min, more preferably 10 min. The second drying is preferably carried out in a blast drying oven, and the second drying temperature is preferably 25-45°C, more preferably 37°C.

[0075] In the present invention, the preparation flow chart of the transdermal microneedle patch with photothermal effect is as follows: Figure 1 shown.

[0076] The present invention provides the use of the above-mentioned transdermal microneedle patch with photothermal effect in the preparation of photothermal therapy medical materials.

[0077] The transdermal microneedle patch with photothermal effect and its preparation method and application provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the scope of protection of the present invention.

[0078] Example 1

[0079] The preparation method of the transdermal microneedle patch with photothermal effect adopts the following steps:

[0080] (1) Preparation and pouring of needle tip solution

[0081] Preparation of microneedle tip solution: weigh Fe 3 O 4 10 mg of nanoparticles were placed in 20 mL of ultrapure water, vortexed and ultrasonicated to form a uniformly dispersed solution, and then 1.0 g of hyaluronic acid was added and stirred evenly with a mechanical stirrer to obtain Fe 3 O 4The nanoparticle concentration was 0.5 mg / mL in a 5% (w / v) hyaluronic acid solution.

[0082] Casting of microneedle tip: Fe 3 O 4 A 5% (w / v) hyaluronic acid solution of nanoparticles was added to the PDMS mold, and the mixture was centrifuged repeatedly at 4500 rpm for 10 min to fill the gaps at the microneedle tip, and then dried in a forced air drying oven.

[0083] (2) Preparation and pouring of base solution

[0084] Preparation of microneedle base solution: add 1.0 g of hyaluronic acid, place in 20 mL of ultrapure water, and stir mechanically to obtain a 5% (w / v) hyaluronic acid solution.

[0085] Casting of microneedle base: After the needle tip is dry, add 5% (w / v) hyaluronic acid solution several times, centrifuge, dry to form a base supporting the microneedle, and finally dry in a 37°C air drying oven. After the microneedle patch is carefully peeled off, Fe 3 O 4 @MNP.

[0086] Structural characterization and performance testing

[0087] ① The Fe 3 O 4 @MNP was used to take photos with a mobile phone and observe and record the overall morphology of the microneedles using an ordinary optical microscope. 3 O 4 @MNP digital photo Figure 2 As shown in the optical microscope image Figure 3 As shown in the scanning electron microscope image Figure 4 shown.

[0088] ② Use energy dispersive spectrometer to determine the obtained Fe 3 O 4 @The element distribution of C, O, and Fe at the MNP tip. The results are as follows Figure 5 As shown. Figure 5 It can be seen that the elemental spectrum confirms the presence of Fe, indicating that Fe 3 O 4 Nanoparticles have been successfully encapsulated into microneedles.

[0089] ③ The obtained Fe 3 O 4 @MNP was tested for mechanical properties, and the resulting mechanical displacement curve is shown in the figure below. Figure 6 As shown. Figure 6 Fe 3 O 4@MNP's compression force at full tip height deformation reaches 0.22N / needle, which is much higher than the minimum force required to pierce the skin (0.1N).

[0090] ④ Using ex vivo pig skin as a microneedle puncture organism to evaluate Fe 3 O 4 @MNP's ability to penetrate the skin, the results are as follows Figure 7 As shown. Figure 7 It can be seen that Fe 3 O 4 @MNP can easily pierce pig skin, leaving neatly arranged pinholes on the surface and destroying the stratum corneum to form microchannels.

[0091] ⑤ The obtained Fe 3 O 4 The photothermal performance of @MNP was analyzed by using a near-infrared laser (NIR) emitter with different laser powers (Beijing Yanbang RN-808nm-2W, 808nm) to irradiate the microneedle tip and using an infrared thermal imager to capture and record the Fe 3 O 4 @MNP real-time temperature change to evaluate its photothermal conversion capability. 3 O 4 @MNP temperature rise curve under different power NIR irradiation Figure 8 As shown, the Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 ) Infrared thermal imaging before irradiation and after NIR irradiation for 5 minutes Fig. 9 As shown. Figure 8 , Fig. 9 It can be seen that under near-infrared light irradiation, Fe 3 O 4 The temperature of the @MNP increases rapidly in a short time (<60s) and then remains stable. These temperature rise curves also show a positive correlation between temperature and near-infrared irradiation power. The infrared thermal images provide clear visual evidence that under near-infrared irradiation, Fe 3 O 4 The temperature of @MNP increases dramatically, while the temperature change of MNP is very small.

[0092] ⑥ Fe 3 O 4 @MNP conducted three cycles of laser on / off experiments to evaluate Fe 3 O 4@MNP photothermal stability. The specific operation is: turn on the laser light source for 5 minutes, turn off the laser light source, wait for 5 minutes for the microneedle patch to cool to room temperature, and then turn on the laser light source to irradiate the microneedle patch. The temperature change diagram in the laser on / off cycle experiment is shown in Fig.10 As shown by Fig.10 It can be seen that after three NIR laser on / off cycles, no significant decay of the temperature increase was observed, revealing that Fe 3 O 4 High photothermal stability of @MNPs.

[0093] The Fe 3 O 4 The in vivo photothermal performance of @MNPs, the results obtained are as follows Fig.11 As shown. In the LPTT group (i.e., Fe 3 O 4 @MNP+NIR), after 2 minutes of near-infrared light irradiation, the maximum temperature of the groin skin area reached about 41.5°C, which was significantly higher than that of other groups.

[0094] Example 2

[0095] The preparation method of the transdermal microneedle patch with photothermal effect adopts the following steps:

[0096] Preparation of microneedle tip solution: Accurately weigh Fe 3 O 4 10 mg of nanoparticles were placed in 20 mL of ultrapure water and vortexed and ultrasonicated to form a uniformly dispersed solution. Then 0.2 g of hyaluronic acid was added and stirred evenly with a mechanical stirrer to obtain Fe 3 O 4 The nanoparticle concentration was 0.5 mg / mL in a 1% (w / v) hyaluronic acid solution.

[0097] Preparation of microneedle base solution: add 1.0 g hyaluronic acid, place in 20 mL ultrapure water, and stir mechanically to obtain a 5% (w / v) hyaluronic acid solution.

[0098] The casting of the microneedle tip and the microneedle base in the subsequent Example 2 is the same as that in Example 1.

[0099] Fe 3 O 4 @MNP digital photo Fig.12 As shown in the optical microscope image Fig.13 As shown, the digital image of pig skin puncture is as follows Fig.14 shown.

[0100] Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm2 The temperature rise curve under irradiation is shown in Fig.15 As shown, the Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 ) Infrared thermal imaging before irradiation and after NIR irradiation for 5 minutes Fig.16 As shown by Fig.15 , 16 It can be seen that under near-infrared light irradiation, Fe 3 O 4 The temperature of @MNPs increased rapidly in a short time (<60s) and then remained stable.

[0101] Example 3

[0102] The preparation method of the transdermal microneedle patch with photothermal effect adopts the following steps:

[0103] Preparation of microneedle solution: Accurately weigh Fe 3 O 4 10 mg of nanoparticles were placed in 20 mL of ultrapure water, vortexed and ultrasonicated to form a uniformly dispersed solution, and then 2.0 g of hyaluronic acid was added and stirred evenly with a mechanical stirrer to obtain Fe 3 O 4 The nanoparticle concentration was 0.5 mg / mL in a 10% (w / v) hyaluronic acid solution.

[0104] Preparation of microneedle base solution: add 1.0 g of hyaluronic acid, place in 20 mL of ultrapure water, and stir mechanically to obtain a 5% (w / v) hyaluronic acid solution.

[0105] The casting of the microneedle tip and the microneedle base in the subsequent Example 3 is the same as that in Example 1.

[0106] Fe 3 O 4 @MNP digital photo Fig.17 As shown in the optical microscope image Fig.18 As shown, the digital image of pig skin puncture is as follows Fig.19 shown.

[0107] Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 The temperature rise curve under irradiation is shown in Fig. 20 As shown, the Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 ) Infrared thermal imaging before irradiation and after NIR irradiation for 5 minutes Fig.21 As shown by Fig. 20 , 21 It can be seen that under near-infrared light irradiation, Fe 3 O 4 The temperature of @MNPs increased rapidly in a short time (<60s) and then remained stable.

[0108] Example 4

[0109] The preparation method of the transdermal microneedle patch with photothermal effect adopts the following steps:

[0110] Preparation of microneedle solution: Accurately weigh Fe 3 O 4 2 mg of nanoparticles were placed in 20 mL of ultrapure water, vortexed and ultrasonicated to form a uniformly dispersed solution, and then 1.0 g of hyaluronic acid was added and stirred evenly with a mechanical stirrer to obtain Fe 3 O 4 The nanoparticle concentration was 0.1 mg / mL in a 5% (w / v) hyaluronic acid solution.

[0111] Preparation of microneedle base solution: add 1.0 g of hyaluronic acid, place in 20 mL of ultrapure water, and stir mechanically to obtain a 5% (w / v) hyaluronic acid solution.

[0112] The casting of the microneedle tip and the microneedle base in the subsequent Example 4 is the same as that in Example 1.

[0113] Fe 3 O 4 @MNP digital photo Fig. 22 As shown in the optical microscope image Fig.23 As shown, the digital image of pig skin puncture is as follows Fig.24 shown.

[0114] Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 The temperature rise curve under irradiation is shown in Fig.25 As shown, the Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 ) Infrared thermal imaging before irradiation and after NIR irradiation for 5 minutes Fig.26 As shown by Fig.25 , 26 It can be seen that under near-infrared light irradiation, Fe 3 O 4 The temperature of @MNPs increased rapidly in a short time (<60s) and then remained stable.

[0115] Example 5

[0116] The preparation method of the transdermal microneedle patch with photothermal effect adopts the following steps:

[0117] Preparation of microneedle solution: Accurately weigh Fe 3 O 4 20 mg of nanoparticles were placed in 20 mL of ultrapure water, vortexed and ultrasonicated to form a uniformly dispersed solution, and then 1.0 g of hyaluronic acid was added and stirred evenly with a mechanical stirrer to obtain Fe 3 O 4 The nanoparticle concentration was 1.0 mg / mL in a 5% (w / v) hyaluronic acid solution.

[0118] Preparation of microneedle base solution: add 1.0 g of hyaluronic acid, place in 20 mL of ultrapure water, and stir mechanically to obtain a 5% (w / v) hyaluronic acid solution.

[0119] The casting of the microneedle tip and the microneedle base in the subsequent Example 5 is the same as that in Example 1.

[0120] Fe 3 O 4 @MNP digital photo Fig. 27 As shown in the optical microscope image Fig.28 As shown, the digital image of pig skin puncture is as follows Fig.29 shown.

[0121] Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 The temperature rise curve under irradiation is shown in Fig.30 As shown, the Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 ) Infrared thermal imaging before irradiation and after NIR irradiation for 5 minutes Fig.31 As shown by Fig.30 , 31 It can be seen that under near-infrared light irradiation, Fe 3 O 4 The temperature of @MNPs increased rapidly in a short time (<60s) and then remained stable.

[0122] Example 6

[0123] The preparation method of the transdermal microneedle patch with photothermal effect adopts the following steps:

[0124] Preparation of microneedle solution: Accurately weigh Fe 3 O 410 mg of nanoparticles were placed in 20 mL of ultrapure water, vortexed and ultrasonicated to form a uniformly dispersed solution, and then 1.0 g of sodium alginate was added and stirred evenly with a mechanical stirrer to obtain Fe 3 O 4 The nanoparticle concentration was 0.5 mg / mL in 5% (w / v) sodium alginate solution.

[0125] Preparation of microneedle base solution: add 1.0 g of hyaluronic acid, place in 20 mL of ultrapure water, and stir mechanically to obtain a 5% (w / v) hyaluronic acid solution.

[0126] The casting of the microneedle tip and the microneedle base in the subsequent Example 6 is the same as that in Example 1.

[0127] Fe 3 O 4 @MNP digital photo Fig.32 As shown in the optical microscope image Fig.33 As shown, the digital image of pig skin puncture is as follows Fig.34 shown.

[0128] Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 The temperature rise curve under irradiation is shown in Fig.35 As shown, the Fe 3 O 4 @MNP in NIR (808nm, 1.25W / cm 2 ) Infrared thermal imaging before irradiation and after NIR irradiation for 5 minutes Fig.36 As shown by Fig.35 , 36 It can be seen that under near-infrared light irradiation, Fe 3 O 4 The temperature of @MNPs increased rapidly in a short time (<60s) and then remained stable.

[0129] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A transdermal microneedle patch with photothermal effect, characterized in that: It comprises a microneedle base and a plurality of microneedle tips arranged in an array and disposed on the surface of the microneedle base; The components of the microneedle tip include a gel matrix and Fe3O4 nanoparticles distributed inside the gel matrix; the raw materials of the gel matrix include hyaluronic acid and / or sodium alginate.

2. The transdermal microneedle patch with photothermal effect according to claim 1, characterized in that: The particle size of the Fe3O4 nanoparticles is 5 to 20 nm.

3. The transdermal microneedle patch with photothermal effect according to claim 1 or 2, characterized in that: In the microneedle tip, the mass ratio of Fe3O4 nanoparticles to gel matrix is ​​0.002-0.02:0.2-2.

4. The transdermal microneedle patch with photothermal effect according to claim 1, characterized in that: The shape of the microneedle tip is a quadrangular pyramid, and the bottom side length of a single microneedle tip is 100 to 1000 μm, and the height is 300 to 1500 μm.

5. The transdermal microneedle patch with photothermal effect according to claim 1, characterized in that: The raw material of the microneedle base includes hyaluronic acid.

6. The method for preparing the transdermal microneedle patch with photothermal effect according to any one of claims 1 to 5, comprising the following steps: The Fe3O4 nanoparticles, the raw materials of the gel matrix and water are mixed to obtain a needle tip solution; Mixing the raw materials of the microneedle base with water to obtain a base solution; The needle tip solution is poured onto the needle tip portion of the microneedle patch mold, and after a first centrifugation and a first drying, the base solution is poured onto the base portion of the microneedle patch mold, and a second centrifugation, a second drying and demoulding are performed to obtain a transdermal microneedle patch with a photothermal effect.

7. The preparation method according to claim 6, characterized in that: The concentration of Fe3O4 nanoparticles in the needle tip solution is 0.1-1.0 mg / mL.

8. The preparation method according to claim 6, characterized in that: The concentration of the base solution is 3-6 w / v%.

9. The preparation method according to claim 6, characterized in that: The first centrifugation and the second centrifugation are performed at a rate of 250 to 4500 rpm and for a time of 5 to 15 min; The temperature of the first drying and the second drying is 25-45°C.

10. Use of the transdermal microneedle patch with photothermal effect as claimed in any one of claims 1 to 5 or the transdermal microneedle patch with photothermal effect prepared by the preparation method as claimed in any one of claims 6 to 9 in the preparation of medical materials for photothermal therapy.